Skip to main content
. 2014 Jun 3;14:303. doi: 10.1186/1471-2334-14-303

Table 2.

Demographic and Clinical Predictors of Oesophageal Varices among 91 Patients with Endoscopic Diagnoses

Demographic or clinical parameter Patients without varices (N = 27) median (IQR) or number (%) Patients with varices (N = 64) median (IQR) or number (%) Univariable odds ratio [95% CI]* P-value*
Sex
 
 
 
0.88
Female
11 (41%)
25 (39%)
1 [reference]
 
Male
16 (59%)
39 (61%)
1.07 [0.43-2.68]
 
Age, years
 
 
 
0.002
15-29
6 (22%)
11 (17%)
1 [reference]
 
30-44
6 (22%)
35 (55%)
3.18 [0.85-11.9]
 
45-59
3 (11%)
12 (19%)
2.18 [0.44-10.9]
 
≥ 60
12 (44%)
6 (9%)
0.27 [0.07-1.10]
 
Live within 5 km of the lake
 
 
 
< 0.001
No
19 (70%)
11 (17%)
1 [reference]
 
Yes
8 (30%)
53 (83%)
11.4 [4.00-32.7]
 
Working as a fisherman
 
 
 
0.002***
No
27 (100%)
48 (75%)
***
 
Yes
0
16 (25%)
 
 
Highest education obtained
 
 
 
0.10
No or less than primary
8 (30%)
11 (17%)
1 [reference]
 
Completed primary
12 (44%)
45 (70%)
2.73 [0.90-8.29]
 
Completed secondary
1 (4%)
3 (5%)
2.18 [0.19-25.0]
 
Any college/university
6 (22%)
5 (8%)
0.61 [0.14-2.71]
 
Source of water
 
 
 
< 0.001***
Piped/river/other
27 (100%)
31 (48%)
***
 
Lake
0
33 (52%)
 
 
Poverty index**
 
 
 
0.61
≤ 4
7 (26%)
20 (31%)
1 [reference]
 
> 4
20 (74%)
44 (69%)
0.77 [0.28-2.11]
 
Alcohol use in the past week
 
 
 
0.19
No
19 (70%)
53 (83%)
1 [reference]
 
Yes
8 (30%)
11 (17%)
0.49 [0.17-1.41]
 
Aspirin/NSAID use in the past week
 
 
 
0.54
No
26 (96%)
62 (98%)
1 [reference]
 
Yes
1 (4%)
1 (2%)
0.41 [0.02-6.85]
 
Prior medical history
 
 
 
 
Reported history of prior haematemesis
 
 
 
0.06
No
21 (78%)
36 (56%)
1 [reference]
 
Yes
6 (22%)
28 (44%)
2.72 [0.97-7.65]
 
Reported history of prior praziquantel use
 
 
 
0.008
No
22 (81%)
32 (50%)
1 [reference]
 
Yes
5 (19%)
32 (50%)
4.40 [1.48-13.1]
 
Clinical examination
 
 
 
 
Mean arterial blood pressure (mmHg)
83 (70–87)
70 (63–82)
0.67 [0.49-0.93]+
0.02
Heart rate (beats per minute)
98 (88–110)
105 (86–111)
1.00 [0.98-1.03]
0.78
Ascites
 
 
 
0.002
No
24 (89%)
32 (50%)
1 [reference]
 
Yes
3 (11%)
32 (50%)
8.00 [2.18-29.2]
 
Hepatomegaly
 
 
 
0.98
No
24 (89%)
57 (89%)
1 [reference]
 
Yes
3 (11%)
7 (11%)
0.92 [0.23-4.12]
 
Splenomegaly
 
 
 
< 0.001
No
23 (85%)
5 (8%)
1 [reference]
 
Yes
4 (15%)
59 (92%)
67.9 [16.7-275]
 
Encephalopathy
 
 
 
0.54
No
26 (96%)
63 (98%)
1 [reference]
 
Yes
1 (4%)
1 (2%)
0.41 [0.02-6.85]
 
Investigations
 
 
 
 
Hepatitis B surface Ag
 
 
 
0.03
Negative
25 (93%)
45 (70%)
1 [reference]
 
Positive
2 (7%)
19 (30%)
5.27 [1.14 – 24.5]
 
Anti-Hepatitis C Ab
 
 
 
0.54
Negative
26 (96%)
63 (98%)
1 [reference]
 
Positive
1 (4%)
1 (2%)
0.41 [0.02-6.85]
 
HIV
 
 
 
0.63
Negative
26 (96%)
60 (94%)
1 [reference]
 
Positive
1 (4%)
4 (6%)
1.73 [0.18 – 16.3]
 
Schistosoma CCA
 
 
 
0.01
Negative
19 (70%)
26 (41%)
1 [reference]
 
Positive
8 (30%)
38 (59%)
3.47 [1.32-9.11]
 
Portal vein, mm
 
 
 
< 0.001
< 13
25 (93%)
3 (5%)
1 [reference]
 
≥ 13
2 (7%)
61 (95%)
254 [40.0-1614]
 
Haemoglobin (g/dL)
6.0 (4.0-9.9)
4.2 (3.6-5.6)
0.76 [0.64-0.91]
0.002
MCV (fl)
82 (71–89)
74 (67–80)
0.59 [0.37-0.92]+
0.02
Platelets (109/L)
150 (103–215)
103 (55–143)
0.70 [0.45-1.11]++
0.13
PTT (seconds)
28 (26–32)
30 (27–35)
1.69 [0.75-3.79]+
0.20
INR (ratio)
1.2 (1.0-1.4)
1.4 (1.1-1.7)
1.37 [0.51-3.63]
0.53
Total bilirubin (μmol/L)
8.8 (5.2-12.7)
13.2 (7.7-21.7)
1.07 [1.01-1.16]
0.04
Albumin (g/L)
35 (30–44)
32 (28–39)
0.74 [0.44-1.24]+
0.25
AST (U/L)
22 (19–29)
28 (19–49)
1.23 [0.96-1.57]+
0.10
ALT (U/L) 17 (14–27) 23 (15–47) 1.20 [0.97-1.49] 0.09

*Results from logistic regression models (Wald p-values).

**Poverty index > 4 indicates that a person does not have multidimensional poverty.

***Unable to calculate odds ratio due to a zero; p-value from Fisher's exact test.

+Per 10 units higher.

++Per 100 units higher.